Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 1

Interventions

Fulvestrant 62Paclitaxel 52Letrozole 51pembrolizumab 39Trastuzumab 38ribociclib 37Capecitabine 36Specimen Handling 34palbociclib 33Carboplatin 33Anastrozole 33exemestane 30Tamoxifen 30abemaciclib 29Cyclophosphamide 26pertuzumab 25Magnetic Resonance Spectroscopy 25trastuzumab deruxtecan 24Surveys and Questionnaires 20Blood Specimen Collection 20Radiotherapy 19olaparib 17Biopsy 16130-nm albumin-bound paclitaxel 16Standard of Care 15Docetaxel 15eribulin 14Methods 14Early Intervention, Educational 14inavolisib 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms × 68Ga-FAPI × 90 days × Clear all
NCT07553741 2026-04-28

Application and Comparison of [68Ga]Ga-FAPI-04 PET, [18F]FDG PET, and Contrast-Enhanced MRI in Predicting Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer Patients

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase NA Completed
27 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡